MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    In vivo positive amyloid PET in a patient with PDD, always reliable?

    S. Enriquez, D. Samaniego, C. Lorenzo-Bosquet, E. Martinez-Saez, A. Garcia-Serra, B. Garcé, S. Belmonte, J. Hernández-Vara (Barcelona, Spain)

    Objective: To describe a singular case of an early-onset Parkinson disease (PD) patient with PD dementia who presented in vivo positive 18 F-Flutebetamol PET but…
  • 2023 International Congress

    How helpful is the Swallow tail sign in Parkinson’s disease?

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi, Kuwait)

    Objective: To report a patient diagnosed with idiopathic Parkinson’s disease (PD) with an intact Swallow tail sign (STS) shown in his MR susceptibility-weighted imaging (SWI)…
  • 2023 International Congress

    Teleprogramming Reduces the Time Needed to Optimize DBS Therapy: Results from the ROAM-DBS study

    A. Gharabaghi, D. Weiss, S. Groppa, L. Lopez Manzanares, A. Schnitzler, R. Alvarez, L. Muñoz-Delgado, C. Luca, J. Karl, V. Marshall, L. Zhang, M. Soileau, B. Dalm, M. Feldman, S. Zauber, H. Lei, L. Luo, B. Walter, C. Wu (Tübingen, Germany)

    Objective: To present early outcomes from the ROAM-DBS (Deep Brain Stimulation) trial on the clinical efficacy of teleprogramming for DBS demonstrating more rapid improvement when…
  • 2023 International Congress

    A multimodal approach for diagnosis of early Multiple System Atrophy (MSA)

    D. Claassen, J. Iregui, P. Trujillo, A. Wynn, C. Wong, M. Bradbury, D. Stamler (Nashville, USA)

    Objective: To describe the use of neuroimaging and fluid biomarkers to improve the diagnostic accuracy of early MSA. Background: The diagnosis of early MSA is…
  • 2023 International Congress

    Long-term evolution of advanced Parkinson’s disease burden: second interim results from the international PROSPECT observational study

    P. Sanchez Alonso, O. de Fabregues, A. Lehn, T. Oeda, F. Ory-Magne, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, V. Fung (Majadahonda, Spain)

    Objective: To evaluate the long-term evolution of clinical and economic outcomes and treatment patterns of patients with advanced Parkinson’s disease (PD) who have symptoms that…
  • 2023 International Congress

    Kufor-Rakef syndrome, report of two unrelated cases from Chile studied with DAT-PET

    P. Saffie, E. Fernandez, S. Mariacca, P. Salles, P. Chana (Santiago, Chile)

    Objective: To describe two previously unreported, unrelated cases of atypical parkinsonism caused by mutations in ATP13A2gene. Background: ATP13A2 gene, previously known as PARK 9, has recently…
  • 2023 International Congress

    Quantification of Striatal and Extrastriatal Dopamine Transporters with [18F]PR04.MZ and [18F] PI- 2620 PET in Patients with Progressive Supranuclear Palsy.

    X. Pizarro, P. Salles, P. Chana, V. Kramer (santiago, Chile)

    Objective: We aim to evaluate the differences in striatal subregional dopamine transporter loss between Parkinson disease (PD) and progressive supranuclear palsy (PSP) of any stage…
  • 2023 International Congress

    Novel utilization of deep brain stimulation in the pedunculopontine nucleus for treatment of childhood-onset dystonia

    J. Davies, J. Kurtz, J. Maclean, T. Sanger, M. Liker, J. Olaya (Orange, USA)

    Objective: Investigate the efficacy of deep brain stimulation (DBS) in the pedunculopontine nucleus (PPN) for the treatment of dystonia in pediatric patients. Background: Deep brain…
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Comparative Effects of Medical Treatment and Tension Deactivation Via Electromyography Biofeedback Intervention to Improve Maximum Mouth Opening in Individuals With Bruxism

    MYA. Amine, U. El-Dakrory (Giza, Egypt)

    Objective: comparing the effects of muscle relaxants and NSAIDs with EMG biofeedback in improving maximum mouth opening in bruxism. Background: Bruxism is an extrapyramidal system…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley